Concepedia

Author

Lujia Dong

Beijing Dao Pei Hospital

Also Known As

Dong L, Fausto Loberiza, L J Dong, Lu-Jia Dong, Lu-jia Dong, Lujia Dong, Lu‐Jia Dong

47

Publications

976

Citations

13

H-Index

26

Concepts

All Affiliations

Beijing Dao Pei HospitalUniversity of FloridaPeking UniversityShenzhen Genoimmune Medical InstitutePeking University People's Hospital
LD

About

Lujia Dong is an author at Beijing Dao Pei Hospital specializing in medicine, transplantation, and marrow transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

83

2

Cellular Therapies

2

2

46

3

Immunology

2

2

46

4

Blood Transplantation

1

1

31

5

Cell Biology

1

1

24

Lujia Dong

×

16

Publications

901

Citations

13

H-Index

YearCitations

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

Dao-Pei Lu, Lujia Dong, Tong Wu,

Blood

2005

510

The Impact of Human Herpesvirus 6B Reactivation on Early Complications following Allogeneic Hematopoietic Stem Cell Transplantation

Liru Wang, Lujia Dong, Mei‐Jie Zhang,

Biology of Blood and Marrow Transplantation

2006

56

First-in-Man CD123-Specific Chimeric Antigen Receptor-Modified T Cells for the Treatment of Refractory Acute Myeloid Leukemia

Yi Luo, Lung‐Ji Chang, Yongxian Hu,

Blood

2015

54

Functional Improvement of Chimeric Antigen Receptor Through Intrinsic Interleukin-15Rα Signaling

Sushmita Nair, Jingbo Wang, Shih-Ting Tsao,

Current Gene Therapy

2018

45

CD3+ Cell Dose and Disease Status Are Important Factors Determining Clinical Outcomes in Patients Undergoing Unmanipulated Haploidentical Blood and Marrow Transplantation after Conditioning Including Antithymocyte Globulin

Lujia Dong, Tong Wu, Mei‐Jie Zhang,

Biology of Blood and Marrow Transplantation

2007

33

Adoptive Transfer of Cytomegalovirus/Epstein-Barr Virus-specific Immune Effector Cells for Therapeutic and Preventive/Preemptive Treatment of Pediatric Allogeneic Cell Transplant Recipients

Lujia Dong, Zhiyong Gao, Lung‐Ji Chang,

Journal of Pediatric Hematology/Oncology

2009

31

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung‐Ji Chang, Lujia Dong, Yuchen Liu,

Blood

2016

31

Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

Lihua Yang, Xiaoli Ma, Yuchen Liu,

Blood

2017

24

LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer Cells

Jianguang Wang, Shuaijun Dong, Jianfeng Zhang,

Cancer Biotherapy and Radiopharmaceuticals

2020

24

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Lujia Dong, Lung‐Ji Chang, Zhiyong Gao,

Blood

2015

20

Page 1